Clinical Significance of LncRNAs SOX2-OT and NEAT1 in Esophageal Squamous Cell Carcinoma

Author:

Kumar Rajiv Ranjan1,Mohanta Adrija1,Rana Manjit Kaur2,uttam Vivek1,Tuli Hardeep Singh3,Jain Aklank1

Affiliation:

1. Non-Coding RNA and Cancer Biology Laboratory, Department of Zoology, Central University of Punjab, Bathinda 151401, Punjab, India

2. Department of Pathology/Laboratory Medicine, All India Institute of Medical Sciences, Bathinda, India

3. Maharishi Markandeshwar University, Mullana

Abstract

Abstract Despite strides in diagnostic and therapeutic approaches for ESCC, patient survival rates remain relatively low. Recent studies highlight the pivotal role of long non-coding RNAs (lncRNAs) in regulating diverse cellular activities in humans. Dysregulated lncRNAs have emerged as potential diagnostic indicators across various cancers, including ESCC. However, further research is necessary to effectively leverage ESCC-associated lncRNAs in clinical settings. Understanding their clinical significance for ESCC diagnosis and their mechanisms can pave the way for more effective therapeutic strategies. Our qRT-PCR observations indicated significant downregulation of SOX2-OT and NEAT1 in ESCC blood samples (SOX2-OT down by ~ 2.02-fold and NEAT1 down by ~ 1.53-fold). The decreased expression of SOX2-OT and NEAT1 shows promise in differentiating ESCC patients from healthy individuals, as demonstrated by Receiver Operating Characteristics (ROC) curves and Area Under the Curve (AUC) values (AUC: SOX2-OT = 0.736, NEAT1 = 0.621) for ESCC diagnosis. Subsequent investigations explored the relationship between aberrant SOX2-OT and NEAT1 expression in ESCC patients and various clinicopathological features, including age, gender, smoking habits, alcohol consumption, hot beverage intake, tumor grade, and TNM stages. In-depth in-silico analysis unveiled the involvement of SOX2-OT and NEAT1 in miRNA sponging through the mTOR and MAPK pathways. In contrast, co-expression network analysis identified genes co-expressed with these lncRNA targets. This groundwork lays the foundation for future endeavours aimed at identifying and predicting ESCC prognosis by leveraging SOX2-OT and NEAT1. By thoroughly investigating the functions of these lncRNAs, we aim to deepen our understanding of their potential as diagnostic markers and their role in facilitating effective therapeutic interventions for esophageal squamous cell carcinoma (ESCC) within clinical contexts.

Publisher

Research Square Platform LLC

Reference63 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay J;Int J Cancer,2019

2. Global time trends in the incidence of esophageal squamous cell carcinoma;Wang QL;Clin Epidemiol,2018

3. Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India;Rana MK;Cureus,2021

4. Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma;Xi Y;Signal Transduct Target Ther,2022

5. Screening for esophageal squamous cell carcinoma: recent advances;Codipilly DC;Gastrointest Endosc,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3